SELLAS Life Sciences Group, Inc. entered into a Warrant Inducement Agreement on September 10, 2025, allowing a holder to cash exercise 19.7 million shares at $1.20 each, generating approximately $23.6 million. The company will issue new warrants for the same number of shares at an exercise price of $1.88, with specific restrictions on further stock issuance for a 90-day period.